Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions


This research trial studies health-related symptom questionnaires in measuring quality of life in human immunodeficiency virus (HIV)-infected participants treated with or monitored for anal lesions. Collecting information and symptoms from patients diagnosed with anal lesions may help reduce the risk of anal cancer.

Study Start Date

April 2015

Estimated Completion Date

August 2016


  • Other: Comprehension Assessment
  • Other: Concept Elicitation


  • Infectious Disease: HIV/Immunodeficiency
  • Gastroenterology: Colorectal Cancer/Polyps
  • Oncology: Colorectal Cancer/Polyps

MeSH Terms

  • Carcinoma in Situ

Study ID

AIDS Malignancy Clinical Trials Consortium -- AMC-A02



Trial ID


Study Type


Trial Phase


Enrollment Quota



AIDS Malignancy Clinical Trials Consortium

Inclusion Criteria

  • HIV-1 infection
  • Biopsy-proven anal HSIL within the prior six months
  • Life expectancy of greater than 5 years

Exclusion Criteria

  • History of anal cancer
  • Inability to understand a written consent form




35 Years and older

Accepts Healthy Volunteers


Study Locations and Contact Information (5)

Study Location Distance Name Phone Email
Montefiore Medical CenterEinstein Campus - Bronx, New York 40.3 miles Mark H Einstein 718-904-2730
Memorial SloanKettering Cancer Center - New York, New York 50.7 miles Jack E Burkhalter 646-888-0040
Cornell Clinical Trials Unit - New York, New York 51.4 miles Timothy J Wilkin 212-746-1848
Laser Surgery Care - New York, New York 51.4 miles Stephen E Goldstone 212-242-6500
Anal Dysplasia Clinic - Chicago, Illinois 747.2 miles Gary Bucher MD 314-825-2625 provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.